OBIO · Orchestra BioMed Holdings, Inc.
$5.43
-0.12 (-2.16%)
At close · Aug 20
Market Cap
$333.58M
Shares
60.11M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.43
Open$5.53
Day$5.38–5.58
52W close$2.35–5.66
Avg vol 30d265K
Short int2.4M · 4.0% float · 13.4d
Short vol56%
DataAug 2020–Aug 2026
Filing10-Q · Aug 10
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 10, 2026
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Very Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+29%
above
Price vs 50-day avg
+32%
above
RSI (14)
75
overbought
MACD trend
Positive
52-week position
93%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+49%
trailing
6-month return
+24%
trailing
YTD return
+31%
this year
Relative strength
+13%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
+17% holders QoQ · +24 funds added
Insider flow
Accumulating
Net +$19.2K over 90 days · 0% sells
Short interest
Falling
4.04% of float · ▼ -6.3% MoM · 13.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
76 holders — near 3-yr high, broad support
Squeeze score
86
high risk · 0–100
Fundamentals
Revenue growth
+1169%
Y/Y
EPS growth
+33%
Y/Y
Free cash flow
$-49.5M
Balance sheet
$19.7M
net cash
Quant / Vol
risk profile
Volatility
70%
annualized · 1-yr
Max drawdown
−35%
past year
ATR
5.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+29%
Bullish
Price vs 50-day avg
+32%
Bullish
RSI (14)
75
Bearish
MACD trend
Positive
Bullish
52-week position
93%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 4 of 6
Trend (MA cross)
No cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
+17% holders QoQ · +24 funds added
Insider flow
Accumulating
Net +$19.2K over 90 days · 0% sells
Short interest
Falling
4.04% of float · ▼ -6.3% MoM · 13.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
76 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $2
Now $5 · 93%
Range high $6
vs 200-day avg +29%
vs 50-day avg +32%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OBIO
this stock
Orchestra BioMed Holdings, Inc.
|
$333.58M | +30.8% | +1169.2% | — | 4.0% |
|
ONC
BeOne Medicines Ltd.
|
$557.05B | +21.5% | +22179.2% | 856.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +19.2% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.39B | +7.1% | +20.8% | 20.8 | 3.3% |
|
MRNA
Moderna, Inc.
|
$69.62B | +352.1% | +4.3% | — | 12.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OBIO | +22.0% | +49.2% | +24.0% | +36.4% | +30.8% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +24.0% | +45.9% | +12.8% | +34.4% | +19.0% |
Key facts
CIK
1814114
CUSIP
68572M106
13F (30d)
72 filings
72 filers
Visit website
Investor relations